Michael Amoroso is President, Chief Executive Officer and Director of Precision BioSciences Inc (DTIL). The company reported total compensation of $2,189,467 for fiscal year 2025.
| Salary | $650,875 |
|---|---|
| Bonus | $451,294 |
| Stock awards | $1,025,086 |
| Option awards | $0 |
| Non-equity incentive plan | $0 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $62,212 |
| Total | $2,189,467 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Precision BioSciences Inc filed April 8, 2026, accession 0001140361-26-013757.
| Peer-group chief executive median | $4,479,043 |
|---|---|
| Difference from that median | $-2,289,576 |
| Percentile within the disclosed peer group | 1st |
| Peers with a disclosed figure | 4 |
Medians and percentiles are computed across the peer group Precision BioSciences Inc discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Michael Amoroso this page | President, Chief Executive Officer and Director | $2,189,467 |
| Alex Kelly | Chief Financial Officer | $1,134,116 |
| Dario Scimeca | General Counsel and Secretary | $911,641 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Precision BioSciences Inc compensation brief.
Michael Amoroso's compensation sits inside Precision BioSciences Inc's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.